Q1 2024 Holdings
Filed 2024-04-22 | 42 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Soleno Therapeutics Inc(SLNO) | Common | 834203309 | $360.3M | 8,418,093 | 28.3% |
| Geron Corp(GERN) | Common | 374163103 | $89.8M | 27,225,292 | 7.1% |
| Harmony Biosciences Holdings Inc(HRMY) | Common | 413197104 | $87.5M | 2,606,247 | 6.9% |
| Sinovac Biotech Ltd.(SVA) | SHS | P8696W104 | $76.3M | 11,800,000 | 6.0% |
| Avadel Pharmaceuticals PLC | ADR | 05337M104 | $67.1M | 3,972,099 | 5.3% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $58.1M | 3,610,177 | 4.6% |
| ALX Oncology Holdings Inc(ALXO) | Common | 00166B105 | $47.1M | 4,220,048 | 3.7% |
| Dyne Therapeutics Inc(DYN) | Common | 26818M108 | $46.4M | 1,635,136 | 3.6% |
| Terns Pharmaceuticals Inc(TERN) | Common | 880881107 | $43.7M | 6,657,992 | 3.4% |
| Astria Therapeutics Inc(CATBUSD) | Common | 04635X102 | $32.8M | 2,329,027 | 2.6% |
| Viridian Therapeutics Inc(VRDN) | Common | 92790C104 | $29.4M | 1,678,207 | 2.3% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $23.9M | 1,105,454 | 1.9% |
| Olema Pharmaceuticals Inc(OLMA) | Common | 68062P106 | $21.2M | 1,873,704 | 1.7% |
| Adverum Biotechnologies, Inc.(AVU0) | Common | 00773U207 | $21.2M | 1,500,000 | 1.7% |
| Alpine Immune Sciences Inc(NVLSEUR) | Common | 02083G100 | $20.8M | 520,505 | 1.6% |
| Tarsus Pharmaceuticals Inc(TARS) | Common | 87650L103 | $20.6M | 565,550 | 1.6% |
| Verastem Inc(VSTM) | Common | 92337C203 | $18.2M | 1,538,461 | 1.4% |
| Crinetics Pharmaceuticals Inc(CRNX) | Common | 22663K107 | $16.4M | 350,000 | 1.3% |
| Cogent Biosciences Inc(COGT) | Common | 19240Q201 | $15.1M | 2,244,941 | 1.2% |
| Sera Prognostics Inc(SERA) | Common | 81749D107 | $15.0M | 1,650,440 | 1.2% |
| Regulus Therapeutics Inc(RGLS) | Common | 75915K309 | $14.4M | 5,000,000 | 1.1% |
| Tourmaline Bio Inc.(TRML) | Common | 89157D105 | $13.6M | 591,882 | 1.1% |
| Compass Pathway PLC(CMPS) | SPONSORED ADS | 20451W101 | $13.4M | 1,608,000 | 1.1% |
| Oric Pharmaceuticals Inc(ORIC) | Common | 68622P109 | $11.7M | 849,681 | 0.9% |
| Engene Holdings Inc.(ENGN) | Common | 29286M105 | $11.5M | 678,705 | 0.9% |
| Genetron Holdings Ltd | ADS | 37186H209 | $10.9M | 2,708,056 | 0.9% |
| IO Biotech Inc(IOBT) | Common | 449778109 | $10.7M | 6,173,439 | 0.8% |
| Savara Inc(SVRA) | Common | 805111101 | $10.4M | 2,088,323 | 0.8% |
| Zai Lab Ltd(ZLAB) | ADR | 98887Q104 | $8.5M | 531,198 | 0.7% |
| Delcath Systems, Inc.(DCTH) | Common | 24661P807 | $8.0M | 1,666,746 | 0.6% |
| Rezolute Inc(RZLT) | Common | 76200L309 | $7.1M | 2,797,704 | 0.6% |
| Compass Therapeutics Inc(CMPX) | Common | 20454B104 | $7.0M | 3,556,023 | 0.6% |
| Instil Bio Inc(TIL) | Common | 45783C200 | $6.7M | 624,338 | 0.5% |
| Q32 Bio Inc.(QTTB) | Common | 746964105 | $6.3M | 370,068 | 0.5% |
| Bolt Therapeutics Inc(BOLT1EUR) | Common | 097702104 | $4.9M | 3,521,291 | 0.4% |
| Unicycive Therapeutics | Common | 90466Y103 | $4.8M | 3,470,152 | 0.4% |
| Allakos Inc(ALLKGUSD) | Common | 01671P100 | $3.8M | 2,988,000 | 0.3% |
| Aligos Therapeutics Inc | Common | 01626L105 | $3.5M | 3,547,030 | 0.3% |
| DBV Technologies SA | SPONSORED ADS | 23306J101 | $2.0M | 2,708,875 | 0.2% |
| Codexis, Inc(CDXS) | Common | 192005106 | $1.4M | 388,144 | 0.1% |
| Aadi Bioscience Inc(WHWK) | Common | 00032Q104 | $1.2M | 509,572 | 0.1% |
| Precision Biosciences Inc(DTIL) | Common | 74019P207 | $63.4K | 4,675 | 0.0% |